Nature editor Noah Gray asked four neuroscience bloggers to write an opinion piece for the September issue of Nature Reviews Neuroscience, called "The neurobiology of psychedelic drugs: implications for the treatment of mood disorders." Here are the results:
Distorted perceptions and an altered state of mind: two reasons why psychedelics have always attracted not only fascination, but also controversy for decades. A recent Perspective in Nature Reviews Neuroscience entitled "The neurobiology of psychedelic drugs: implications for the treatment of mood disorders", by Franz Vollenweider & Michael Kometer explores why there is a renewed interest in the clinical potential of psychedelics for treating mental disorders, after nearly a 40 year gap in clinical experimentation. Anticipating a significant interest in this topic, Nature Publishing Group has made this manuscript freely accessible for 1 month. In addition, we offer a four-part series of essays by some of the best neuroscience bloggers to help you explore the literature and discuss the most important aspects:
1.) The secret history of psychedelic psychiatry by Moheb Costandi
2.) Serotonin, Psychedelics and Depression by Neuroskeptic
3.) Ketamine for Depression: Yea or Neigh? by The Neurocritic
4.) Visions of a psychedelic future by Vaughan Bell
[Thanks Mo!]
The comments posted here do not reflect the views of the owners of this site.